Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asunaprevir and Daclatasvir in Non-Responder Chronic Hepatitis C
NCT01888900Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- May 2013
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of asunaprevir, daclatasvir in hepatitis C (HCV), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started May 2013; status: completed.
02
Drugs
asunaprevirdaclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01888900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01888900.